Concepedia

Publication | Open Access

GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial

DOIFull Paper Access

37

Citations

15

References

2022

Year

Irina Strâmbu, Christian A. Seemayer, Liesbeth Fagard, Paul A. Ford, Tom A.K. Van der Aa, Angela A. de Haas-Amatsaleh, Vikas Modgill, Eva Santermans, Eric Sondag, Eric Helmer,
European Respiratory Journal

Abstract

Treatment with GLPG1205 did not result in a significant difference in FVC decline <i>versus</i> placebo. GLPG1205 demonstrated a poorer safety and tolerability profile than placebo.

References

YearCitations

Page 1